title: Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction.
authors.affiliation: University Children's Hospital, Heidelberg, Germany.
authors.forename: K M
authors.initials: KM
authors.lastname: Debatin
authors.forename: C
authors.initials: C
authors.lastname: Beltinger
authors.forename: T
authors.initials: T
authors.lastname: Böhler
authors.forename: J
authors.initials: J
authors.lastname: Fellenberg
authors.forename: C
authors.initials: C
authors.lastname: Friesen
authors.forename: S
authors.initials: S
authors.lastname: Fulda
authors.forename: I
authors.initials: I
authors.lastname: Herr
authors.forename: M
authors.initials: M
authors.lastname: Los
authors.forename: C
authors.initials: C
authors.lastname: Scheuerpflug
authors.forename: H
authors.initials: H
authors.lastname: Sieverts
authors.forename: K
authors.initials: K
authors.lastname: Stahnke
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis / Q000276:immunology*; D053222:Fas Ligand Protein; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000502:physiology; D006801:Humans; D015458:Leukemia, T-Cell / Q000276:immunology / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000235:genetics / Q000276:immunology; D008562:Membrane Glycoproteins / Q000502:physiology*; D018448:Models, Immunological; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D019014:fas Receptor / Q000235:genetics / Q000502:physiology*
chemical_list: D000970:Antineoplastic Agents; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D018124:Receptors, Tumor Necrosis Factor; D019014:fas Receptor